Girard Partners LTD. lessened its position in UnitedHealth Group Inc (NYSE:UNH) by 7.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,118 shares of the healthcare conglomerate’s stock after selling 2,818 shares during the quarter. UnitedHealth Group accounts for approximately 1.6% of Girard Partners LTD.’s portfolio, making the stock its 13th largest holding. Girard Partners LTD.’s holdings in UnitedHealth Group were worth $8,810,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Argent Trust Co increased its holdings in shares of UnitedHealth Group by 8.3% in the fourth quarter. Argent Trust Co now owns 13,911 shares of the healthcare conglomerate’s stock worth $3,066,000 after acquiring an additional 1,061 shares in the last quarter. Cornerstone Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 24,755.2% during the second quarter. Cornerstone Wealth Management LLC now owns 245,569 shares of the healthcare conglomerate’s stock worth $992,000 after buying an additional 244,581 shares in the last quarter. Kaizen Advisory LLC grew its holdings in shares of UnitedHealth Group by 150.3% during the second quarter. Kaizen Advisory LLC now owns 2,325 shares of the healthcare conglomerate’s stock worth $570,000 after buying an additional 1,396 shares in the last quarter. Iberiabank Corp bought a new position in shares of UnitedHealth Group during the second quarter worth about $958,000. Finally, Lincoln Capital Corp bought a new position in shares of UnitedHealth Group during the second quarter worth about $875,000. 85.45% of the stock is currently owned by institutional investors and hedge funds.
A number of research analysts recently issued reports on UNH shares. Jefferies Financial Group increased their price objective on UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a report on Wednesday, October 3rd. Argus increased their price objective on UnitedHealth Group to $285.00 and gave the stock a “buy” rating in a report on Thursday, October 18th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $292.00 price objective for the company in a report on Monday. Morgan Stanley increased their price objective on UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a report on Wednesday, September 5th. Finally, ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. Two research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $292.48.
In other news, Director Kenneth Irwin Shine sold 163 shares of UnitedHealth Group stock in a transaction on Friday, November 9th. The stock was sold at an average price of $274.83, for a total value of $44,797.29. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Steven H. Nelson sold 26,033 shares of the business’s stock in a transaction on Friday, September 7th. The stock was sold at an average price of $270.65, for a total value of $7,045,831.45. The disclosure for this sale can be found here. In the last quarter, insiders sold 60,428 shares of company stock worth $16,232,134. Corporate insiders own 0.87% of the company’s stock.
Shares of UNH opened at $282.55 on Friday. UnitedHealth Group Inc has a 52-week low of $208.48 and a 52-week high of $285.45. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69. The firm has a market capitalization of $260.86 billion, a PE ratio of 28.06, a price-to-earnings-growth ratio of 1.56 and a beta of 0.78.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The company had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. During the same quarter last year, the company posted $2.66 EPS. The company’s revenue for the quarter was up 12.4% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Inc will post 12.8 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Stockholders of record on Monday, December 3rd will be paid a $0.90 dividend. The ex-dividend date is Friday, November 30th. This represents a $3.60 annualized dividend and a dividend yield of 1.27%. UnitedHealth Group’s payout ratio is 35.75%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Retained Earnings
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.